Next Day Disclosure Return
Filed with HKEX · Stock code 2595 · · 6 pages · English
Genfleet Therapeutics (Shanghai), Inc. on 6ix
Earlier from Genfleet Therapeutics (Shanghai)
- VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurchase
- Share repurchase
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
- VOLUNTARY ANNOUNCEMENT Multiple Innovative Combination Therapies of Oral Pan RAS Inhibitor GFH276 Recently Granted with Clinical Trial Approvals for First-line and Late-line Clinical Studies Addressing Major Tumor Indications in China or Abroad
Later from Genfleet Therapeutics (Shanghai)
All Genfleet Therapeutics (Shanghai) news releasesFollow Genfleet Therapeutics (Shanghai) into a list and get an email when it puts out news.
Follow Genfleet Therapeutics (Shanghai)